PPARD and psoriasis: The reversibility of the PPARδ agonist-induced effect by the synergistic action of a PPARδ agonist and antagonist was also described in skeletal muscle cells (C2C12 line) [35], in a mouse model of psoriasis [33], and in human umbilical vein endothelial cells (HUVEC) [34].